World RNA Series
Upcoming Events in the World RNA Series
We have seen enormous strides in the developments and breakthroughs in RNA-based vaccines, RNA-based therapeutics and targeting RNA fields since the onset of the global pandemic. Keeping pace with the field's rapid advancements, the World RNA Series from Hanson Wade continues to provide unrivaled industry-focused events to help deliver safe and effective RNA therapies to patients faster.
Get a comprehensive overview of the upcoming events within the World RNA Series portfolio below. If you have any questions, get in touch at info@hansonwade.com.
July 11-13, 2023 | Boston, MA
Optimize RNA Editing Technology to Safely Deliver Novel Payloads, Enhance Potency & Durability to Achieve Clinical Validation in Patients Faster
July 26-28, 2023 | Boston, MA
Unlock mRNA Platforms for Next Generation Therapeutics & Vaccines from Concept to Clinical Validation & Commercialization for Patients in Need Across All Disease Indications
August 23-24, 2023 | Boston, MA
Successfully Develop Sensitive, Reproducible, High-Throughput Screening Tools & Assays to Optimize Hit Finding for Accelerated RNA-Targeted Drug Discovery
August 29-31, 2023 | Berlin, Germany
Confidently Improve mRNA Characterisation, Quality & Potency with Novel Analytical Tools for Efficient Approval & Commercial Release of Your mRNA Therapeutics & Vaccines
September 5-7, 2023 | Boston, MA
Unlock Native & Engineered Exosomes with Improved Targeting, Optimize Analytics & Achieve GMP Manufacturing for Effective Translation into the Clinic & Towards Commercialization
September 26-28, 2023 | Boston, MA
Accelerating mRNA Process Development & Manufacturing from Research to Commercial Scale with Increased Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness
October 10-12, 2023 | Boston, MA
Improve Immunogenicity, Delivery & CMC of mRNA Cancer Vaccines Towards Accelerated Discovery, Translation & Clinical Development of Next Generation Cancer Treatments for Patients
December 12-14,2023 | Boston, MA
Improve Rational Design, Specificity & Selectivity of Small Molecules Targeting RNA to Enable Safe & Effective Drugs to Accelerate into the Clinic
Returning 2024:
Strengthen Safe & Effective mRNA Pipelines of Vaccines & Therapeutics by Improving Cell Specific Payload Expression, Durability & Immunogenicity towards Accelerated Development & Regulatory Approvals
Returning January 2024 | Berlin, Germany
Pioneer Novel Analytical & Biological Assays & Tools to Robustly Characterize Safety, Consistency & Efficacy of Your mRNA Therapeutics & Vaccines for Accelerated Approval
Returning February 2024 | Boston, MA
Accelerating Extrahepatic Delivery, CMC & Clinical Development of Targeted siRNA Therapeutics for Modular, Reproducible & Effective Gene Silencing Therapies Against Oncology, CNS, Rare Diseases & Beyond
Returning March 2024 | Boston, MA
Accelerating the End to End of mRNA Process Development & Manufacturing, From Research to Commercial Scale Maximizing Efficiency, Stability & Therapeutic Applicability for Regulatory & Market Readiness
Returning April 2024, Frankfurt, Germany
Stay Ahead of the Curve with Novel RNA Therapeutics that Offer Exceptional Stability & Durability Whilst Addressing Key Delivery, Pharmacology & Scalability Challenges to Successfully Translate Safe & Effective Next Generation RNA Therapeutics into the Clinic
Returning May, 2024| Boston, MA
Supporting Optimized Purity, Stability & Raw Material Testing for Vaccine Developers to Set Quality Standards at Scale & Avoid GMP Obstacles to Accelerate the Development & Release of Safe & Effective mRNA Medicines
Returning June, 2024 | Boston, MA